ASS1 and melanoma: We therefore depleted ASS1-low melanoma cell lines (A375 and SK-MEL-28) from arginine via treatment with arginine deiminase (ADI), an enzyme catalyzing the degradation of arginine, and subjected total RNA to RNA004 tRNA-seq.